7 Recruiting AML Phase 1 Clinical Trials
Active phase 1 studies for aml enrolling across the USA. Verify eligibility and contact site coordinators.
All AML studiesPhase 1 Studies for AML
🔵 Active, Not Recruiting Phase1 / Phase2
ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial
📍 The University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1
CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
📍 University of California, Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔ 🟢 Recruiting Phase1
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1
CC-486 and Venetoclax for Acute Myeloid Leukemia
📍 CU Anschutz Medical Campus — Aurora, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase1
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
📍 UT MD Anderson — Houston, Texas
View Study & Checklist ➔